Business Description
Tonix Pharmaceuticals is a US-based drug development company focused on treatments for brain and nervous system conditions, immune disorders, infectious diseases, and rare conditions. Its marketed products include TONMYA for fibromyalgia and two migraine treatments, Zembrace SymTouch and Tosymra. The company also has a broad pipeline of experimental therapies targeting conditions such as depression, cocaine intoxication, kidney transplant rejection, Lyme disease, Prader-Willi syndrome, smallpox, and several cancers, among others. Founded in 2007 and headquartered in Berkeley Heights, New Jersey, Tonix handles both the development and commercialization of its products internally.
